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A B ST R AC T 
 
 
Lipomas, the most common type of benign tumours, are generally developed 
from adipose tissue and present an incidence of 2.1 per 1000 inhabitants. In 
addition to lipomas, at least three other maladies of the adipose tissue lead 
patients to consult a doctor, especially for aesthetic purposes: multiple 
familial lipomatosis, diffuse congenital lipomatosis, and adiposa doloris. 
Unlike lipomas, these maladies are characterized by numerous lipomas, 
encapsulated or not, of different sizes, symmetrical or not, which may appear 
in the neck, limbs, or the trunk, sometimes being painful. The life quality of 
these patients is affected, not only from an aesthetic point of view but also 
from medical considerations, like pain. Chemical lipolysis has proven 
unsatisfactory for patients due to several reasons: the prolonged therapy, 
high cost, the partial dissolution of the lipomatosis, and high recurrence at 
one year. Surgical treatment remains the only viable option; sometimes 
when numerous lipomatous tumors required large and numerous incisions, 
treatment was refused by patients. The result after laser liposuction is 
excellent, the recovery time is short, without much pain for the patient, with 
minimal ecchymoses and edemas, without any recurrence in time, and with 
an excellent degree of patient satisfaction.   
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Lipomas are the most common type of benign tumours 
developed from adipose tissue. These are generally well-
located and of varying sizes, can appear at any age, in both 
sexes, and can manifest in several clinical forms. Benign 
adipose tumours can be classified into solitary lipomas, 
multiple familial lipomatosis, and diffuse congenital 
lipomatosis (benign symmetrical lipomatosis) [1]. 
Our practice has uncovered a number of cases of 
patients, from subjects who presented for a single lipoma 
(with clinical manifestations and/ or esthetic aspects) to 
those who presented with multiple lipomas of different 
sizes, sometimes more than 30 lipomas with or without 
clinical manifestations. 
Most often lipomas did not have clinical manifestations 
but, even when these were present, the main reason for 
consultation with the doctor was an aesthetic purpose, 
regardless of age. The main concern of these patients has 
been “How will it look after we remove it? Will, there be 
any scar?" Every surgeon is aware that the biological 
process of scarring has particularities from one patient to 
another, and that scarring is sometimes unpredictable as an 
esthetic result. Thus, if patients presented with one or more 
lipomas on areas of the body covered by clothing, they 
more easily accepted the surgery. In contrast, when patients 
presented with 10 or 20 lipomas, most on the upper limbs 
or even in the cervical region, more discussion and 
clarification with patients were needed. Usually, patients 
wanted to remove lipomas because they were aesthetically 
disturbing but, at the same time, they wanted the guarantee 
that they would not leave unsightly scars. 
In this clinical context, and taking into account the 
psychological implications for the patient, we have tested 
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a variety of solutions in the treatment of multiple lipomas. 
The first therapeutic alternative was represented by 
chemical lipolysis. It consists of directly injecting an 
emulsifying substance into the adipose tissue, such as 
phosphatidylcholine (PPC) and deoxycholic acid (DOC). 
Injected active substances cause the slow progressive 
dissolution of the fat cells, without leading to an increase 
of triglycerides in the blood. The fat released is 
subsequently metabolized by the liver. Usually, 2-4 
treatments are necessary (at 4-8-week intervals) for the 
procedure to be successful [2]. Treatments can also be 
performed at shorter intervals, more precisely about two 
weeks, in which case dose selection is essential. Each 
session lasts about 30 minutes and should dissolve 1-3 cm 
from the fat layer. In fact, the lipomas would not disappear 
completely in most women, and treatment/ healing times 
after each session were long, so that over time most 
patients became less compliant at treatment; in addition, 
we have noticed numerous recurrences, a finding 
confirmed by other authors [2, 3]. The degree of patient 
satisfaction, as well as our degree/ professional 
appreciation, was sometimes low, so that we sought other 
therapeutic options. The second alternative for us, as well 
as for other authors [4], was surgical ablation through small 
excisions. This solution was not very agreeable when the 
location of the lipomas was in aesthetic/visible areas, and 
in cases where the number of lipomas was very high, the 
patients objected to multiple incisions.  
Given these goals (to treat lipomas through minimal 
scarring, in a short amount of time, and with a minimum 
recovery period), we decided to purchase a NdYag 1064 
laser, Deka SmartLipo, whose preset indication and work 
schedule are specific to the treatment of lipomas. Since the 
1980s, liposuction has been used in the treatment of 
multiple familial lipomatosis [5]. Laser lipolysis has been 
recently introduced in the treatment protocol for lipomas 
therapy, and the indications, procedures, and the long-term 
diagnosis/ outcomes are still under debate [6]. 
Discussions 
The main difficulty/challenge is to understand exactly 
what the patient wants, and how important the aesthetic 
result is for him/her. Thus, before choosing the form of 
treatment, it is useful (both for the patient and physician) 
to identify the patient's wishes and expectations so as to 
obtain a maximum degree of post-therapeutic satisfaction. 
In this regard, we have developed a questionnaire that the 
patient must complete before surgery and during medical 
consultations. 
Pre-treatment assessment questionnaire:  
1. What is the main reason you want lipoma(s) removal? 
- for esthetic purposes  
- for medical purposes: localized pain  
- prophylactic purposes (fear of malignant 
transformation)  
2. How important is the aesthetic result and a possible scar 
for you?  
- very important  
- important 
- little or no important 
3. What is the time interval you could offer for treatment 
and recovery? 
- 1 week (for laser treatment) 
- 2-4 weeks 
- 1-3 months 
4. What is your first treatment option? 
- laser lipolysis  
- chemical lipolysis 
- surgical ablation  
5. What is the main criterion in choosing the treatment? 
- the cost of the treatment 
- duration of the treatment and recovery period  
- the esthetic result. 
The second challenge was to establish indications and 
contraindications for laser treatment. The NdYag laser may 
be used for the following indications [7]: 
- lipomas smaller than 5 cm, well-outlined, mobile, that 
do not affect any nerve and that have not presented an 
accelerated growth in the last months 
- benign symmetrical lipomatosis (Madelung’s malady) 
- diffuse familial lipomatosis 
Relative contraindication: 
- Dercum’s disease  
Absolute contraindication: 
- bulky lipomas with suspicion of liposarcoma  
General contraindications of the laser for liposuction: 
- uncontrollable high blood pressure  
- cardiac failure  
- decompensated diabetes 
- pregnancy  
- mental disorders 
We also needed to consider the potential for 
malignancy, which is increased for lipomas over 5-6 cm 
and, from this perspective, laser-assisted liposuction has 
the disadvantage of not preserving tissue fragments for 
biopsy. In such cases, we prefer surgical excision of the 
large lipomas or, as a last resort, the classic liposuction 
with the histopathological examination of the various 
tissue fragments and, possibly, with the lipo laser. 
Preoperatively, we recommend a minimal set of 
laboratory tests and, for painful lipids or a location near a 
nerve or vessel, soft tissue ultrasound is recommended. 
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The treatment is performed under local anesthesia for 
small lipomas, or intravenous sedation / general anesthesia 
for large lipomas, numerous lipomas, or patients with a 
history of panic attacks or phobias of different etiologies.  
The procedure is relatively accessible. The anesthesia 
is followed by the minimal infiltration of the lymphomas 
with Klein solution [6], followed by a 2-3 mm incision 
through which the lipo laser cannula is inserted. The 
program is preset for lipids by the device, but can be 
adjusted manually, depending on the size of the lipids and 
the response to treatment. For lipomas larger than 1 cm, 
classical liposuction can be combined with laser lipolysis. 
The working technique: 
For liposuction, small cannulas 3-4 cm thick were used, 
with a single minimal incision. For laser lipolysis, a 300 
µm fiber, with 6-8 W power and 3,000-6,000 J energy was 
used for a single lipoma depending on its size. The 
advantages of NdYag laser therapy are: 
- a single session is usually necessary 
- the recovery period is minimal, i.e., 2-4 days, with 
reduced discomfort 
- it can also be performed with a local anaesthesia 
- all lipomas can be treated in a single session 
- it can concomitantly perform a skin tightening, so that 
for superficial and medium-sized lipomas the excision 
of the skin was not necessary 
- in most cases no local skin bruising occur 
- the aesthetic appearance is remarkable and often a 19G 
needle is sufficient (instead of making a minimal 
incision), while healing should not leave scars. The 
incisions are closed with intradermal 5.0 absorbable 
threads 
After the procedure, patients are daily monitored, and 
prophylactic antibiotic therapy could be administered 
(Augmentin or Oxacylin of 500 mg for 5-7 days); 
painkillers and anti-inflammatory drugs (Paracetamol, 
Tador, Doreta) are also administered, and in case of small 
ecchymoses, arnica-based solutions (Arnigel) are 
administered as well. For the prevention of unaesthetic 
scars, Contractubex or Stratamed can be applied for three 
months after the intervention. 
The results obtained with Deka SmartLipo laser are 
generally very good. In addition to all the advantages 
mentioned above, patients are aesthetically satisfied, an 
important aspect because most patients present 
themselves to the doctor with concern about the aesthetic 
aspects of the lipomas. 
After treatment, the patient should evaluate his/her 
degree of satisfaction: 
1. Are you satisfied with the treatment administered? 
- very satisfied (3 points) 
- satisfied (2 points) 
- unsatisfied (1 point) 
2. Are you satisfied with the final esthetic result? 
- very satisfied (3 points) 
- satisfied (2 points) 
- unsatisfied (1 point) 
3. How much has your quality of life improved? 
- very much (4 points) 
- satisfactorily (3 points) 
- a little (2 points) 
- very little (1 point) 
Based on this form, the patient's degree of satisfaction 
after the laser-assisted liposuction can be established: 
• 9-10 points – an excellent result, a high degree of 
satisfaction 
• 7-8 points – very good result, a good degree of 
satisfaction 
• Under 7 points – the average result, low degree of 
satisfaction 
The lipoma is a benign affliction, with an incidence of 
2.1 per 1000 persons. The location of these lipomas can 
sometimes be atypical. They may be encountered in 
various areas, such as at the level of the scrotum; when 
lipomas present low consistency they can be confused with 
external hernias [8]. In the case of development of 
lipomatous masses within the mediastinum, the differential 
diagnosis must be made with tumours or even with 
diaphragmatic hernias. Other possible differential 
diagnoses are with neurofibromas, schwannomas, synovial 
cysts, etc., depending on location [9, 10]. The treatment of 
solitary lipomas is usually surgical, but the laser lip may be 
considered, depending on the location, size, and preference 
of the patient. For lipomas larger than 5 cm and with rapid 
growth, the only safe therapeutic approach remains 
surgical ablation, with a histopathological examination to 
exclude possible liposarcoma.  
Multiple familial lipomatosis was first described in 
1970 by Das Gupta as a benign affliction characterized by 
the occurrence of numerous encapsulated lipomas [11], 
unlike diffuse congenital lipomatosis in which the lipomas 
are not encapsulated. The angiolipoma differentiates from 
the lipoma through the presence of capillary proliferation 
and slight fibrosis of the connective tissue. The incidence 
of multiple familial lipomatosis is approximately 0.002%, 
being rarely encountered. It is a disease with 
predominantly autosomal dominant transmission, although 
cases of recessive autosomal transmission have also been 
reported [12]. Lipomatosis can also be associated with 
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Madelung’s disease, Gardner’s syndrome (a hereditary 
disease characterized by the presence of multiple polyps in 
the colon, in association with bone tumours and soft tissue 
tumours), or Dercum’s disease (painful adiposity, which 
mainly affects women at menopause) [13]. Even if they  
are frequently associated with polyneuropathy, the 
relationship between these maladies is still under 
discussion, the main causative factor being represented by 
the cytopathy of the mitochondria and the disorders of the 
lipid metabolism [14]. 
Benign symmetrical lipomatosis is characterized by the 
presence of some adipose masses of large dimensions, 
slightly circumscribed, of soft consistency, painless, non-
encapsulated, usually located at the cervical level and the 
extremities. The lipomatous masses develop in the 
subcutaneous cellular tissue and frequently infiltrate the 
adjacent planes. The disease generally affects men between 
30-60 years old, the men/women ratio ranging between 
15/1 and 30/1, the most extensive spread being recorded in 
Mediterranean countries [15]. Benign symmetrical 
lipomatosis can occur sporadically, or it may be familial 
(with dominant, autosomal transmission). The incidence of 
the disease is 1 to 250,000 [16]. It is also known as 
Madelung’s disease, Launois-Bensaude’s adeno-
lipomatosis, Brodie’s syndrome, or Buschke’s disease. The 
disease is frequently associated with alcohol consumption, 
over 90% of the patients being chronic alcohol users [17] 
and with polyneuropathy [18]. More than two-thirds of the 
patients are overweight, which is also an aggravating factor 
of the disease, accelerating the development of lipomatous 
masses [16].  
From a clinical perspective, two types have been 
described. Type I, in which lipomas are located in the 
cervical region and the supraclavicular and deltoid regions 
(with the occurrence of the so-called “bull-neck”/ 
Madelung’s collar), sometimes with the invasion of the 
mediastinum manifested through the feeling of suffocation 
of the patient as a result of the tracheal compression. Type 
II, in which lipomas are located throughout the body, 
except for the neck, giving the impression of ordinary 
obesity without profound involvement. The possibility of 
malignant transformations is exceptional, although some 
cases of malignancy of familial symmetrical lipomatosis 
have been reported. The diagnosis of symmetrical 
lipomatosis is based on the symmetrical distribution of fat 
deposits and on the fact that the arms and the legs do not 
exhibit areas of lipodystrophy [19-21]. The leading causes 
for the occurrence of this malady could be represented by 
an enzymatic defect or an alteration of the membranous 
receptors (which would lead to a decrease in adrenergic 
lipolysis), or sympathetic denervation of brown adipocytes 
(which would lead to hypertrophy and mitochondrial DNA 
mutations) [22, 23]. It can be associated with different 
metabolic disorders: insulin resistance, hyperuricemia, 
renal tubular acidosis, the increase of hepatic enzymes 
(cytolysis, cholestasis), disorders of the thyroid gland, of 
the adrenal glands, of the hypophysis. Paradoxically, there 
is an increase in high-density lipoproteins (HDL) [24-26]. 
Liposuction seems to be the best treatment option for those 
that are superficially located, although it cannot prevent 
recurrences [27, 28]. The prognosis mainly depends on the 
concomitance of neuropathy which may significantly 
increase mortality [16].  
Dercum’s disease, also called adiposis dolorosa or 
neurolipomatosis, is an unusually progressive disease of 
unknown etiology, characterized by the occurrence of 
some multiple lipomas, encapsulated or not, painful, which 
frequently occur in overweight women at menopause. The 
onset is insidious. The pain is due to the compression of the 
lipomas on the nerves, being described by the patients as 
“the fat that hurts”. Its hereditary transmission is 
dominantly autosomal, from mother to daughter [29-31]. 
The mechanisms of the disease are still unknown, and the 
origin of the pain remains uncertain. The histopathological 
exam does not show any differences between these 
tumours and the regular lipomas. The diagnostic criteria for 
neurolipomatosis comprise the four cardinal symptoms: 
multiple and painful fat masses; generalized obesity 
especially at menopause; asthenia, weakness, and fatigue; 
and mental changes with emotional instability, depression, 
confusion, and dementia. The conditions associated with 
adiposis dolorosa include sleep disturbances, irritable 
bowel, carpal tunnel syndrome, Tietze syndrome, thyroid 
dysfunction, tendonitis and myalgia [32-35]. 
Three clinical types of Dercum’s disease have been 
described: 
• type I, the juxta-articular type, with folds or painful fat 
in the knees and the thighs  
• type II, diffuse/ generalized, with the extension of the 
pain  
• type III, the nodular type, with intense pain in and 
around the multiple lipomas attached to the adjacent 
tissue.  
The diagnosis is difficult to make, because there are no 
specific signs or symptoms, and even the histopathological 
examination cannot provide a diagnosis of certainty. 
Differential diagnosis must be made with progressive 
lipodystrophy, Proteus syndrome, fibromyalgia, 
myasthenia gravis, Madelung’s syndrome, 
neurofibromatosis, and Cushing’s syndrome [36, 37]. 
Moreover, associated pathologies at the dermal-epidermal 
level can overlap the lipomas [38-40]. 
No treatment can alter the course of the disease, and 
those available are symptomatic only. The use of systemic 
corticosteroids, intravenous anesthetics, and analgesics are 
indicated. Liposuction produces a significant improvement 
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of the pain and the quality of life with the mention that the 
lowest laser energies should be used since lipomas are 
often connected to nerves that should be protected from 
heat emitted by the laser, this aspect generating thus 
distinct options (the relative indication or contraindication) 
of the lipo laser for this sickness [41, 42]. 
Highlights 
✓ Lipomatosis has a relatively rare incidence, is well 
localized and occurs at any age in both sexes in 
patients with congenital or familial lipomatosis. 
✓ Taking into account the psychological implications for 
the patient we have always tried alternative solutions 
in the treatment of multiple lipomas, and laser therapy 
with NDYAG 1064 NM LASER seems to be an 
optimal choice. 
Conclusions 
Although multiple lipomatosis is relatively rare, its 
treatment option is still challenging because most patients 
present to the doctor for an aesthetic purpose. Chemical 
lipolysis proved to have poor results, with a long period of 
treatment and high costs for the patient, so we no longer 
consider it a feasible therapeutic alternative. Surgical 
excision is often refused by patients, even if it involves 
minimal incisions, mainly due to the numerous resulting 
postoperative scars, whose evolution is often 
unpredictable. In this context, we consider that laser 
liposuction would be the optimal treatment for these 
maladies, with mention that patients must be well 
examined preoperatively. When lipomas are large or 
painful, the ultrasound of soft parts is also necessary to 
specify the anatomical relationships with the surrounding 
tissues. There were no recurrences in the studied group 
until the date of publication of this paper.  
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